BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24297795)

  • 1. Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.
    Sanchez-Infantes D; White UA; Elks CM; Morrison RF; Gimble JM; Considine RV; Ferrante AW; Ravussin E; Stephens JM
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E217-25. PubMed ID: 24297795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling.
    van Krieken PP; Odermatt TS; Borsigova M; Blüher M; Wueest S; Konrad D
    Mol Metab; 2021 Dec; 54():101341. PubMed ID: 34547509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
    Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
    J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocyte Oncostatin Receptor Regulates Adipose Tissue Homeostasis and Inflammation.
    Sanchez-Infantes D; Stephens JM
    Front Immunol; 2020; 11():612013. PubMed ID: 33854494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes.
    Bailey JL; Hang H; Boudreau A; Elks CM
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity.
    Piquer-Garcia I; Campderros L; Taxerås SD; Gavaldà-Navarro A; Pardo R; Vila M; Pellitero S; Martínez E; Tarascó J; Moreno P; Villarroya J; Cereijo R; González L; Reyes M; Rodriguez-Fernández S; Vives-Pi M; Lerin C; Elks CM; Stephens JM; Puig-Domingo M; Villarroya F; Villena JA; Sánchez-Infantes D
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e337-48. PubMed ID: 31606738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin m impairs brown adipose tissue thermogenic function and the browning of subcutaneous white adipose tissue.
    Sánchez-Infantes D; Cereijo R; Peyrou M; Piquer-Garcia I; Stephens JM; Villarroya F
    Obesity (Silver Spring); 2017 Jan; 25(1):85-93. PubMed ID: 27706920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
    Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M promotes lipolysis in white adipocytes.
    van Krieken PP; Roos J; Fischer-Posovszky P; Wueest S; Konrad D
    Adipocyte; 2022 Dec; 11(1):315-324. PubMed ID: 35531859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.
    Komori T; Tanaka M; Furuta H; Akamizu T; Miyajima A; Morikawa Y
    Diabetologia; 2015 Aug; 58(8):1868-76. PubMed ID: 25972231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.
    White UA; Stewart WC; Stephens JM
    Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of oncostatin M receptor β (OSMRβ) exacerbates high-fat diet-induced obesity and related metabolic disorders in mice.
    Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
    J Biol Chem; 2014 May; 289(20):13821-37. PubMed ID: 24695736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
    Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
    Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Hematopoietic Cell-Derived Oncostatin M Worsens Diet-Induced Dysmetabolism in Mice.
    Albiero M; Ciciliot S; Rodella A; Migliozzi L; Amendolagine FI; Boscaro C; Zuccolotto G; Rosato A; Fadini GP
    Diabetes; 2023 Apr; 72(4):483-495. PubMed ID: 36657995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic modifications of the Zfp/ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.
    Longo M; Raciti GA; Zatterale F; Parrillo L; Desiderio A; Spinelli R; Hammarstedt A; Hedjazifar S; Hoffmann JM; Nigro C; Mirra P; Fiory F; Formisano P; Miele C; Smith U; Beguinot F
    Diabetologia; 2018 Feb; 61(2):369-380. PubMed ID: 29067487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncostatin M in the development of metabolic syndrome and its potential as a novel therapeutic target.
    Komori T; Morikawa Y
    Anat Sci Int; 2018 Mar; 93(2):169-176. PubMed ID: 29103176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M and its receptors mRNA regulation in bovine granulosa and luteal cells.
    Martins KR; Haas CS; Ferst JG; Rovani MT; Goetten ALF; Duggavathi R; Bordignon V; Portela VVM; Ferreira R; Gonçalves PBD; Gasperin BG; Lucia T
    Theriogenology; 2019 Feb; 125():324-330. PubMed ID: 30504073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Oncostatin M and Its Receptor Complexes in Cardiomyocyte Protection, Regeneration, and Failure.
    Kubin T; Gajawada P; Bramlage P; Hein S; Berge B; Cetinkaya A; Burger H; Schönburg M; Schaper W; Choi YH; Richter M
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.